Top compounds associated with response to IRGC


Feature Type Standardized
Nominal ANOVA
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.015 0.6
mRNA quizartinib CTRPv2 pan-cancer AAC 0.017 0.6
mRNA LY317615 GDSC1000 pan-cancer AAC 0.015 0.6
mRNA rTRAIL GDSC1000 pan-cancer AAC 0.016 0.7
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.018 0.7
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA cimetidine CTRPv2 pan-cancer AAC -0.03 0.7
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.016 0.7
mRNA FSC231 CTRPv2 pan-cancer AAC -0.032 0.7
Download CSV